Strategic partnership between Elekta and BESA to improve clinical workflows

May 23, 2017

HELSINKI, May 23, 2017 – Elekta (EKTA-B.ST) announced today that Elekta Oy, a fully-owned subsidiary of Elekta AB and a global leading provider of magnetoencephalography (MEG) technology, has entered a long-term strategic partnership with BESA GmbH. The purpose of the partnership is to jointly develop and commercialize clinical software solutions for MEG, with the initial aim of providing a world-class workflow for the pre-surgical evaluation of epileptic patients. The collaboration will later expand to other clinical uses of the Elekta Neuromag® TRIUX™ (http://www.elekta.com/TRIUX) MEG system.

Elekta Oy is the leading supplier of MEG technology with more than 100 MEG systems delivered and a 28-year track record of bringing leading solutions to the market. Founded in 1995, BESA (Brain Electrical Source Analysis) GmbH is a leading supplier of analytical software for MEG and electroencephalography (EEG) with 2,000 customers worldwide.

Janne Huhtala, Head of Elekta’s Global MEG Business, says: “This partnership brings together BESA’s software development experience and Elekta’s MEG experts. Our sole focus will be to create a smooth, clinically appropriate software workflow built on the experience of – and in close collaboration with – our MEG users.”

The announcement was made during the biennial meeting of the International Society for the Advancement of Clinical Magnetoencephalography (ISACM), in Sendai, Japan where both companies were present.

To learn more about Elekta Neuromag, visit www.elekta.com/TRIUX.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, e-mail: raven.canzeri@elekta.com
Time zone: EST: Eastern Standard Time

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

About BESA
BESA GmbH was founded as MEGIS Software GmbH in 1995 by Dr. Michael Scherg. It is the leading company in the field of EEG / MEG analysis and a home base for highly skilled employees. Our products are designed based on 30 years’ experience in human brain research. BESA provides state-of-the-art scientific analysis tools covering the complete range of neurophysiological applications. We strive to bring our customers the latest methods for advanced EEG and MEG analysis in an optimized, user-friendly implementation. BESA GmbH is a privately-owned company headquartered in Germany. www.besa.de

Downloads

Release